![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
南美洲天冬酰胺酶市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(大肠杆菌、菊欧文氏菌、聚乙二醇化等)、应用(治疗、食品加工等)和最终用途行业(医疗保健和食品)制造业)
SAM 天冬酰胺酶市场预计将从 2022 年的 3229 万美元增长到 2028 年的 7324 万美元;预计 2022 年至 2028 年复合年增长率为 14.6%。
新产品发布和批准
由于大量人口不断增长的需求增加了新产品开发、产品发布和区域一级的批准,制药和食品行业不断以显着的速度发展。此外,主要市场参与者都参与研发活动,以确保高效产品的创新和开发。近年来出现了各种发展,例如市场上的产品发布和批准,这可能会在市场上创造充足的机会。例如,2021年7月,Ligand Pharmaceuticals Incorporated与Jazz Pharmaceuticals Plc合作推出Rylaze(天冬酰胺酶Erwinia Chrysanthemi(重组)-rywn),也称为JZP458。 Rylaze 是一种重组欧文氏菌天冬酰胺酶,用作多药化疗方案的组成部分,用于治疗对大肠杆菌来源过敏的成人和 1 个月或以上儿童患者的急性淋巴细胞白血病 (ALL) 或淋巴母细胞淋巴瘤 (LBL)天冬酰胺酶。同样,2020 年 8 月,Lonza 扩大了微生物产能,并与施维雅制药 (Servier Pharmaceuticals, Inc.) 在 L-天冬酰胺酶 API 制造方面延长了长期合作伙伴关系。新工厂将为多个客户提供中型商业生产,并满足独立国际制药公司和龙沙长期合作伙伴施维雅不断增长的需求。因此,市场参与者之间新产品开发、发布和其他战略合作的增加可能会在未来几年创造充足的机会并推动市场增长。
< strong>市场概览
SAM 天冬酰胺酶市场分为巴西、阿根廷和 SAM 的其他地区。巴西在 2022 年占据市场主导地位。根据世界卫生组织报告,2020 年巴西报告了 11,445 例新发非霍奇金淋巴瘤病例和 11,363 例新发白血病病例。随着医疗保健设施和产品的发展,医疗保健设施和产品也不断发展,患病率不断上升。巴西的白血病和淋巴瘤。据国家医学图书馆报道,巴西卫生部于2017年收购了北京双林制药(中国)生产的新型L-天冬酰胺酶,商品名为Leuginase。此外,巴西拥有北美第二大食品加工业,南美洲,仅次于美国。该国还拥有第二大农业产业,并将大部分食品和原料出口到邻国。巴西食品加工行业经历了显着增长,这进一步创造了对天冬酰胺酶的需求。例如,根据巴西食品加工协会的数据,2021年巴西食品加工业创造了1710亿美元的收入,比2020年增长了16.9%。因此,白血病和淋巴瘤的患病率不断上升,随着天冬酰胺酶在农业和农业中的应用激增,该国的食品工业预计将在预测期内激增天冬酰胺酶市场的增长。
到 2028 年 SAM 天冬酰胺酶市场收入和预测(美元)百万)
SAM 天冬酰胺酶市场细分
< p>SAM 天冬酰胺酶市场根据类型、应用、最终用途行业和国家进行细分。根据类型,SAM 天冬酰胺酶市场是分为大肠杆菌、菊欧文氏菌、聚乙二醇化等。到 2022 年,大肠杆菌细分市场占据最大的市场份额。根据应用,SAM 天冬酰胺酶市场分为治疗、食品加工和其他领域。 2022年,治疗细分市场占据最大市场份额。治疗细分市场进一步分为急性淋巴细胞白血病、淋巴母细胞淋巴瘤等。根据最终用途行业,SAM 天冬酰胺酶市场分为医疗保健和食品制造。 2022 年,医疗保健领域占据了更大的市场份额。根据国家/地区,SAM 天冬酰胺酶市场分为巴西、阿根廷和 SAM 的其他地区。我们的区域分析表明,巴西将在 2022 年占据市场主导地位。创意酶;爵士制药公司;梅达克有限公司;施维雅制药有限责任公司;泰姬制药有限公司;和 United Biotech (P) Limited 是 SAM 天冬酰胺酶市场的领先公司。
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Asparaginase Market – By Type
1.3.2 SAM Asparaginase Market – By Application
1.3.3 SAM Asparaginase Market – By End-Use Industry
1.3.4 SAM Asparaginase Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Asparaginase Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Asparaginase Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Leukemia and Increasing Usage Application
5.1.2 Significant Growth of Pharmaceutical and Food Industry
5.2 Market Restraints
5.2.1 Side Effects Associated With Use of Asparaginase
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.4 Future Trends
5.4.1 Increase in R&D Activities and Investment by Market Players
5.5 Impact Analysis
6. Asparaginase Market– SAM Analysis
6.1 SAM Asparaginase Market Revenue Forecasts and Analysis
7. SAM Asparaginase Market Analysis – By Type
7.1 Overview
7.2 By Type: SAM Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Escherichia Coli
7.2.1.1 Overview
7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Erwinia Chrysanthemi
7.2.2.1 Overview
7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
7.2.3 Pegylated
7.2.3.1 Overview
7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)
7.2.4 Others
7.2.4.1 Overview
7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. SAM Asparaginase Market Analysis – By Application
8.1 Overview
8.2 By Application: SAM Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Therapeutic
8.2.1.1 Overview
8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)
8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 Lymphoblastic Lymphoma (LBL)
8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.5 Others
8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Food Processing
8.2.2.1 Overview
8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)
8.2.3 Others
8.2.3.1 Overview
8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)
9. SAM Asparaginase Market Analysis – By End-use Industry
9.1 By End-Use: SAM Market Revenue and Forecast Analysis (US$ Million)
9.1.1 Healthcare
9.1.1.1 Overview
9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)
9.1.2 Food Manufacturing
9.1.2.1 Overview
9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
10. SAM Asparaginase Market – Country Analysis
10.1 Overview
10.1.1 SAM: Asparaginase Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.1.3 Brazil: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.1.4 Brazil: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.1.4.1 Brazil: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.1.5 Brazil: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
10.1.1.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.2.3 Argentina: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.2.4 Argentina: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.2.4.1 Argentina: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.2.5 Argentina: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
10.1.1.3 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.3.3 Rest of SAM: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.3.4 Rest of SAM: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.3.4.1 Rest of SAM: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.3.5 Rest of SAM: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Servier Pharmaceuticals LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Biovendor, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Enzymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Taj Pharmaceuticals Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 medac GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Jazz Pharmaceuticals, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 United Biotech (P) Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)
Table 2. Brazil: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Brazil: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Brazil: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Brazil: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Argentina: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Argentina: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Argentina: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Argentina: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Rest of SAM: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Rest of SAM: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Rest of SAM: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Rest of SAM: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Recent Inorganic Growth Strategies
Table 15. Recent Organic Growth Strategies
Table 16. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Asparaginase Market Segmentation
Figure 2. SAM Asparaginase Market Segmentation, by Country
Figure 3. SAM Asparaginase Market Overview
Figure 4. SAM Asparaginase Market, By Type
Figure 5. SAM Asparaginase Market, By Country
Figure 7. SAM: PEST Analysis
Figure 8. Experts Opinion
Figure 9. SAM Asparaginase Market Impact Analysis of Drivers and Restraints
Figure 10. SAM Asparaginase Market – Revenue Forecasts and Analysis
Figure 11. By Type: SAM Market Analysis and Forecast 2021 and 2028 (%)
Figure 12. SAM Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Pegylated Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. By Application: SAM Market Analysis and Forecast 2021 and 2028 (%)
Figure 17. SAM Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. SAM Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Food Processing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. By End-Use: SAM Market Analysis and Forecast 2021 and 2028 (%)
Figure 24. SAM Healthcare Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM: Asparaginase Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 27. SAM: Asparaginase Market, by Country, 2021 & 2028 (%)
Figure 28. Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 29. Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 30. Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
- Biovendor, LLC
- Creative Enzymes
- Jazz Pharmaceuticals, Inc.
- medac GMBH
- Servier Pharmaceuticals LLC
- Taj Pharmaceuticals Limited
- United Biotech (P) Limited
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM asparaginase market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution